Most Recent
The wife of a billionaire developer has lodged an appeal seeking to suppress the affidavits of a tax official in a $272 million proceeding brought by the Australian Taxation Office.
The law firm that filed a second securities class action against failed Blue Sky Alternative Investments and auditor EY has moved swiftly to stay a competing class action brought three months ago.
The High Court has dismissed an application by accounting giant KPMG to transfer a class action over the collapse of mining company Arrium from Victoria to NSW.
Avant Insurance has lost its bid to challenge a ruling which put it on the hook for indemnifying a plastic surgeon in class action proceedings over allegedly botched breast augmentations at a defunct NSW clinic.
Nine has failed to persuade the High Court to take up a special case that would argue the Racial Discrimination Act infringes the broadcaster's implied right of political speech, in a blow to its defence against a class action over its coverage of litigation related to the Palm Island riots.
Apple has foreshadowed a challenge in the event two law firms seek to work together on a consolidated class action that alleges both Apple and Google engaged in anti-competitive conduct in operating their app stores.
ANZ and Westpac have failed in their bid for a contradictor to weigh in on a contingency fee bid in two class actions, as the law firm that lost the first ever application for a group costs order tries again.
Qantas has won its application to the High Court to appeal a Full Federal Court finding that it breached the Fair Work Act when it outsourced the work of its ground crew during the height of the COVID-19 pandemic.
The High Court has turned down the appeal of the former Blue Star Helium CEO who was hit with a $40,000 penalty and four-year ban after the company failed to disclose to shareholders the identity of the buyer behind a botched sale of Texas oil assets.
The operator of the Royal Perth Hospital has brought legal action against Griffith Hack alleging the law firm contributed to the "dishonest and fraudulent design" of a leading researcher to transfer the intellectual property rights to a stem cell manufacturing method developed inhouse.